Low dose sulphonylurea plus DPP4 inhibitor lower blood glucose and enhance beta cell function without hypoglycaemia
CONCLUSIONS: Low dose sulphonylurea plus DPP4i has potent glucose lowering effect through augmentation of beta cell function. A double-blind randomised controlled trial would formalise efficacy and safety of this combination, which may avoid negative aspects of SU.PMID:38267622 | DOI:10.1210/clinem/dgae033
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Ruth Lorna Mary Cordiner Khaled Bedair Andrea Mari Ewan Pearson Source Type: research
More News: Diets | Endocrinology | Fortamet | Incretin Therapy | Janumet | Januvia | Metformin | Nutrition | Study | Women